Data Tecnica International

Data Tecnica International, commonly known as DataTecnica, is a private data science and technology company headquartered in Bethesda, Maryland, United States. Founded in early 2017 by Dr. Mike Nalls, a statistician and geneticist with extensive experience in large-scale biomedical data analysis, the company focuses on building software tools and platforms that accelerate research across federal health, biotechnology, and philanthropy. Its stated mission is to build better healthcare by accelerating innovation and maximizing the potential of scientific communities. DataTecnica operates at the intersection of artificial intelligence, data science, computer science, biology, and medicine. Its expertise spans machine learning, statistics, bioinformatics, epidemiology, distributed systems, high-performance computing, human-computer interaction, genetics, multi-omics, imaging, neurology, and public health. The company pairs AI-enhanced tooling with forward-deployed subject matter experts to deliver high-quality results for clients and collaborators. Through automation and standardization, DataTecnica aims to increase research efficiency and transparency for large scientific organizations. DataTecnica's client and collaborator base includes organizations in federal health, biotech, and philanthropy. The company is a staunch advocate of open science, making data and code easily accessible to the scientific community. Notable open-source contributions include the release of RoP v2026.04, which harmonized 1.33 million biomedical data elements, and the development of the DataTecnica Genomics Agent, an AI assistant for biomedical research. In May 2026, DataTecnica announced its participation in the NVIDIA Inception program, further strengthening its AI capabilities. The company is led by founder Mike Nalls, PhD, and partner Hirotaka Iwaki, MD, PhD, a board-certified neurologist with a PhD in medical research and a Master of Public Health from the Harvard School of Public Health. DataTecnica's team is diverse, with integrative expertise across all essential areas of data science and technology. The company remains privately held and continues to innovate in global healthcare, tackling problems ranging from mental health, aging, diabetes, and neurological disorders to hospital administration and diagnostic tools.

Data Tecnica International was founded in early 2017 by Dr. Mike Nalls, a scientist with over a decade of experience in large dataset analytics and methods research in healthcare and other scientific fields. Nalls holds more than 550 peer-reviewed publications with an H-index greater than 150, focusing on applied statistics in large datasets, brain diseases, and genomics. He is a strong advocate of open science, collaboration, and transparency in science. The company was established in Bethesda, Maryland, and initially focused on providing data science and technology services to healthcare and scientific organizations. Over time, DataTecnica expanded its capabilities to include artificial intelligence, machine learning, bioinformatics, epidemiology, distributed systems, high-performance computing, human-computer interaction, genetics, multi-omics, imaging, neurology, and public health. A key partner is Hirotaka Iwaki, MD, PhD, a board-certified neurologist in Japan who holds a PhD in medical research and completed a Master of Public Health in the quantitative concentration at the Harvard School of Public Health. Iwaki has extensive experience in managing and analyzing massive datasets in the pharmaceutical, medical, and academic spaces. DataTecnica has built software tools and platforms optimized for clients across federal health, biotech, and philanthropy. The company emphasizes automation and standardization to increase research efficiency and transparency for large scientific organizations. It pairs forward-deployed subject matter experts with open-source pipelines and proprietary AI-assisted tooling. In January 2026, DataTecnica introduced the Genomics Agent, an AI assistant for biomedical research. In May 2026, the company released RoP v2026.04, an open-source harmonization of 1.33 million biomedical data elements, and announced its participation in the NVIDIA Inception program. These developments reflect DataTecnica's ongoing commitment to open science and innovation in healthcare.

• DataTecnica founded by Mike Nalls, PhD, in Bethesda, Maryland.

• DataTecnica Genomics Agent introduced as an AI assistant for biomedical research.

• RoP v2026.04 released as open source, harmonizing 1.33 million biomedical data elements.

• DataTecnica announced participation in the NVIDIA Inception program.

DataTecnica positions itself as a provider of AI-enhanced tooling and forward-deployed subject matter experts that accelerate actionable research and maximize scientific transparency and reproducibility for large scientific organizations.

• DataTecnica Genomics Agent

  An AI assistant for biomedical research, designed to help scientists analyze genomic data.

• RoP (harmonized biomedical data elements)

  An open-source resource that harmonizes 1.33 million biomedical data elements to improve data interoperability.

1. 1Datatecnicadatatecnica.com
2. 2About — Datatecnicadatatecnica.com
3. 3Products — Datatecnicadatatecnica.com
4. 4Data Tecnica International (United States) - Wikidatawikidata.org